JYNT.NASDAQJoint CORP

10-Q: The Joint Corp. Reports Q1 2024 Results, Revenue Up 5% Amid Strategic Shift

Sentiment:

Quarterly Report


The Joint Corp. saw a 5% increase in total revenue in Q1 2024, driven by growth in both company-owned and franchised clinics, while also progressing with its strategic re-franchising plan.

Worse than expectedThe company's net income decreased significantly compared to the same period last year, primarily due to the absence of a one-time employee retention credit.

Summary

  • The Joint Corp. reported a 5% increase in total revenue for the first quarter of 2024, reaching $29.7 million, compared to $28.3 million in the same period last year.
  • This growth was primarily driven by a 2.4% increase in revenue from company-owned or managed clinics and a 10.5% increase in royalty fees from franchised locations.
  • The company's net income for the quarter was $0.9 million, or $0.06 per share, compared to $2.3 million, or $0.16 per share, in Q1 2023.
  • The decrease in net income was largely due to the absence of a $3.8 million employee retention credit received in the prior year period.
  • The company is actively pursuing a strategy to re-franchise the majority of its company-owned clinics, with approximately 76% of the portfolio identified for sale.
  • As of March 31, 2024, The Joint Corp. had 954 clinics in operation, including 819 franchised and 135 company-owned or managed locations.
  • System-wide comparable sales for clinics open at least 13 months increased by 3%, while mature clinics open 48 months or more saw a 3% decrease.
  • The company paid down $2 million of debt under its credit agreement during the quarter.

Sentiment

Score: 6

Explanation: The document presents a mixed picture. While revenue growth and strategic initiatives are positive, the decrease in net income and some operational challenges temper the overall sentiment. The company is in a transition phase, which introduces both opportunities and risks.

Positives

  • The company experienced a solid increase in total revenue, driven by both company-owned and franchised operations.
  • Royalty fees from franchised clinics showed strong growth, indicating a healthy franchise system.
  • The company is actively pursuing a strategic re-franchising plan, which could lead to long-term growth.
  • The company successfully paid down $2 million of debt, improving its financial position.
  • The number of clinics in operation continues to grow, demonstrating the company's expansion.

Negatives

  • Net income decreased significantly compared to the same period last year, primarily due to the absence of a one-time employee retention credit.
  • Mature clinics open for 48 months or more experienced a decrease in comparable sales.
  • Franchise fees decreased due to the impact of accelerated revenue recognition from terminated franchise agreements in the prior year.
  • General and administrative expenses increased, partly due to restructuring costs and higher professional fees.

Risks

  • The company faces risks related to labor shortages and wage increases, which could impact profitability.
  • Inflationary pressures and potential decreases in consumer spending could negatively affect the business.
  • The re-franchising strategy carries execution risks and may not be successful.
  • The company's operating results may fluctuate due to various factors, including economic conditions and competitive pressures.
  • The company is subject to risks related to the corporate practice of chiropractic and potential regulatory changes.

Future Outlook

The company expects to use or redeploy its cash resources to support the business within the context of prevailing market conditions, which could rapidly and materially deteriorate or otherwise change. The company anticipates that 2024 will continue to be a volatile macroeconomic environment.

Management Comments

  • The company seeks to be the leading provider of chiropractic care in the markets it serves.
  • The company believes its refined strategy will leverage its capacity to build a franchise to drive long-term growth.
  • The company believes it has a sound business concept and will benefit from changes in how Americans access chiropractic care.
  • The company's goal is to generate significant processes that will provide value-creating capital allocation opportunities.

Industry Context

The Joint Corp. operates in the competitive chiropractic industry, facing competition from both independent practitioners and other franchise systems. The company's focus on affordable, natural solutions aligns with current consumer trends. The shift away from insurance-based models is also a key industry trend that the company is leveraging.

Comparison to Industry Standards

  • The Joint Corp.'s revenue growth of 5% is a positive sign, but it is important to compare this to the growth rates of other franchise healthcare providers such as Massage Envy or other chiropractic franchise systems.
  • The company's comparable sales growth of 3% is a key metric to watch, as it indicates the health of existing locations. This should be compared to industry benchmarks for same-store sales growth in the healthcare sector.
  • The company's adjusted EBITDA of $3.5 million should be compared to the EBITDA margins of similar franchise businesses to assess its profitability.
  • The company's strategic shift to re-franchising is a significant move and should be compared to other companies that have successfully transitioned from company-owned to franchise models, such as Dunkin' or McDonald's.
  • The company's debt paydown of $2 million is a positive step, but its overall debt levels and leverage ratios should be compared to industry averages to assess its financial health.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Board of DirectorsJefferson Gramm2024-01-02Appointment to serve until the election and qualification of his successor at the 2024 Annual Meeting.

Legal Proceedings

  • The company is party to litigation and claims from time to time in the normal course of business.

Related Party Transactions

  • The company sold franchise licenses to family members and co-partners of a board member, Jefferson Gramm, on terms no less favorable than those that would have been obtained in the absence of such affiliation.
  • A board member, Mr. Gramm, loaned approximately $370,000 to an unaffiliated franchisee.

Stakeholder Impact

  • Shareholders may be impacted by the decrease in net income, but the strategic re-franchising plan could lead to long-term value creation.
  • Franchisees may benefit from the re-franchising of company-owned clinics, providing expansion opportunities.
  • Employees may be impacted by the company's efforts to manage labor costs and address labor shortages.
  • Customers may experience changes in service as the company transitions its clinic portfolio.

Next Steps

  • The company will continue to execute its re-franchising strategy.
  • The company will focus on reinvesting in the brand and related marketing.
  • The company will continue to invest in its IT platforms.
  • The company may consider repurchasing regional developer territories.
  • The company may consider a stock repurchase program.

Key Dates

DateDescription
2020-02-28The company entered into a Credit Agreement with JPMorgan Chase Bank, N.A.
2022-02-28The company amended its Credit Facilities, increasing the Revolver to $20 million.
2024-01-02Jefferson Gramm was appointed to the Board of Directors.
2024-01-17The company paid down $2 million of debt under the Credit Agreement.
2024-03-05The company granted restricted stock to certain high-performing employees.
2024-03-31End of the first quarter of 2024.
2024-05-01The company had 14,973,910 shares of common stock outstanding.

Keywords

chiropractic, franchise, revenue, clinics, re-franchising, EBITDA, sales, growth, healthcare, financial results

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.